Table I. Common pathways towards the development of more effective pharmacologic strategies for Major Depressive Disorder (MDD).

• Develop new agents as monotherapy

• Combine two or more pharmacologic treatments Two or more existing or established agents A combination of existing, established, and new agents

• Identify subpopulations of MDD patients who are more likely to experience the benefits of a given treatment Biological markers Clinical markers